Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)

Our aim was to assess the long-term clinical outcome of boron neutron capture therapy (BNCT) using (10)B-para-boronophenylalanine (BPA) as the boron delivery agent for cutaneous melanoma. Eight patients (eight lesions) were treated between October 2003 and April 2014. Their ages ranged from 48 to 86...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiratsuka, Junichi, Kamitani, Nobuhiko, Tanaka, Ryo, Tokiya, Ryoji, Yoden, Eisaku, Sakurai, Yosinori, Suzuki, Minoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Oncology/Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674695/
https://www.ncbi.nlm.nih.gov/pubmed/32990318
http://dx.doi.org/10.1093/jrr/rraa068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674695/
https://www.ncbi.nlm.nih.gov/pubmed/32990318
http://dx.doi.org/10.1093/jrr/rraa068

Ejemplares similares